A lawyer representing 1,000 women in a class action suit has said that the Health Canada statistics on the drug’s harm to women are “just the tip of the iceberg.”
Yasmin and Yaz "may be associated with a risk of blood clots that is 1.5 to 3 times higher than other birth control pills," according to the Health Canada review.